Current landscape of clinical use of ex vivo expanded natural killer cells for cancer therapy (2024)
Source: Einstein. Unidades: IB, FMRP, Interunidades em Biotecnologia
Subjects: CULTURA DE CÉLULAS, NEOPLASIAS, IMUNOTERAPIA
ABNT
AZEVEDO, Julia Teixeira Cottas de et al. Current landscape of clinical use of ex vivo expanded natural killer cells for cancer therapy. Einstein, v. 22, 2024Tradução . . Disponível em: https://dx.doi.org/10.31744/einstein_journal/2024RW0612. Acesso em: 15 jul. 2025.APA
Azevedo, J. T. C. de, Godoy, J. A. P. de, Souza, C. de, Sielski, M. S., Coa, L. L., Barbosa Júnior, A., et al. (2024). Current landscape of clinical use of ex vivo expanded natural killer cells for cancer therapy. Einstein, 22. doi:https://dx.doi.org/10.31744/einstein_journal/2024RW0612NLM
Azevedo JTC de, Godoy JAP de, Souza C de, Sielski MS, Coa LL, Barbosa Júnior A, Kerbauy LN, Kondo AT, Okamoto OK, Hamerschlak N, Kutner JM, Paiva R de MA. Current landscape of clinical use of ex vivo expanded natural killer cells for cancer therapy [Internet]. Einstein. 2024 ; 22[citado 2025 jul. 15 ] Available from: https://dx.doi.org/10.31744/einstein_journal/2024RW0612Vancouver
Azevedo JTC de, Godoy JAP de, Souza C de, Sielski MS, Coa LL, Barbosa Júnior A, Kerbauy LN, Kondo AT, Okamoto OK, Hamerschlak N, Kutner JM, Paiva R de MA. Current landscape of clinical use of ex vivo expanded natural killer cells for cancer therapy [Internet]. Einstein. 2024 ; 22[citado 2025 jul. 15 ] Available from: https://dx.doi.org/10.31744/einstein_journal/2024RW0612